Galapagos NV
Latest round
- Series A
Last raised
- Mar 2002
Total raised
- $19M
Investors
- 5
About Galapagos NV
Founded in 1999 in Mechelen, Belgium, Galapagos NV focuses on biotechnology solutions.4 mn.28 mn.Galapagos NV specializes in developing innovative biotechnology solutions, including small molecule therapies like the TYK2 inhibitor GLPG3667, which is in Phase 2 trials for systemic lupus erythematosus and other autoimmune conditions. The company also advances its cell therapy platforms, offering scalable and decentralized treatment solutions.2 and an EBITDA of EUR 81,958,111. The company is also poised for growth following its initial public offering in 2005 and is focused on developing its innovative biotechnology solutions to meet the needs of patients with chronic autoimmune diseases.
Who invested in Galapagos NV
5 investors across 1 round
See all investors in Galapagos NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 5, 2002
Amount
$19M
Investors
Questions about Galapagos NV
Who invested in Galapagos NV?
Galapagos NV has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Galapagos NV raised?
Galapagos NV has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Galapagos NV last raise money?
Galapagos NV's most recent round on record is a Series A, in Mar 2002.
What does Galapagos NV do?
Founded in 1999 in Mechelen, Belgium, Galapagos NV focuses on biotechnology solutions.
Where is Galapagos NV headquartered?
Galapagos NV is headquartered in Mechelen, Belgium.
Which VCs invest in companies like Galapagos NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Galapagos NV's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Galapagos NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.